Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
IntroductionCampylobacter is a common pathogen of the gastrointestinal tract, but invasive disease is rare. Campylobacter fetus can play a role in osteomyelitis, meningitis and joint infection and has a prediliction for the vascular endothelium, causing mycotic aneurysms, thrombophlebitis and endocarditis. Here we present a case of prosthetic valve endocarditis caused by C. fetus and a review of the literature.Case presentationAn 85-year-old woman with a tissue aortic valve replacement and atrial fibrillation was admitted to hospital with tonic-clonic seizures, right-sided hemiparesis, facial droop and hemianopia. Multiple cerebral emboli were seen on magnetic resonance imaging of the brain. Blood cultures grew C. fetus and an echocardiogram showed thickening and restricted movement of the aortic valve, a significant difference from an echocardiogram done 2 months before when the same organism was again isolated in blood cultures. She improved after treatment with 6 weeks of amoxicillin and 2 weeks of synergistic gentamicin for prosthetic valve endocarditis.ConclusionThere have only been five previously reported cases of C. fetus prosthetic valve endocarditis and this is the only patient who presented as a stroke. The majority of surviving patients required replacement of the affected valve with only one other patient surviving in the absence of surgery. No guidelines exist on the optimum treatment of C. fetus endocarditis and this case reports adds to the growing literature on the appropriate management for this rare and potentially devastating disease.
IntroductionCampylobacter is a common pathogen of the gastrointestinal tract, but invasive disease is rare. Campylobacter fetus can play a role in osteomyelitis, meningitis and joint infection and has a prediliction for the vascular endothelium, causing mycotic aneurysms, thrombophlebitis and endocarditis. Here we present a case of prosthetic valve endocarditis caused by C. fetus and a review of the literature.Case presentationAn 85-year-old woman with a tissue aortic valve replacement and atrial fibrillation was admitted to hospital with tonic-clonic seizures, right-sided hemiparesis, facial droop and hemianopia. Multiple cerebral emboli were seen on magnetic resonance imaging of the brain. Blood cultures grew C. fetus and an echocardiogram showed thickening and restricted movement of the aortic valve, a significant difference from an echocardiogram done 2 months before when the same organism was again isolated in blood cultures. She improved after treatment with 6 weeks of amoxicillin and 2 weeks of synergistic gentamicin for prosthetic valve endocarditis.ConclusionThere have only been five previously reported cases of C. fetus prosthetic valve endocarditis and this is the only patient who presented as a stroke. The majority of surviving patients required replacement of the affected valve with only one other patient surviving in the absence of surgery. No guidelines exist on the optimum treatment of C. fetus endocarditis and this case reports adds to the growing literature on the appropriate management for this rare and potentially devastating disease.
We report the first case of homograft endocarditis caused by Campylobacter jejuni, which was treated successfully with antibiotic therapy and valve replacement. To our knowledge, only two other cases of C. jejuni endocarditis, involving native valves, have been reported in the medical literature. CASE REPORTIn May 2009, a 46-year-old male born in Morocco and living in The Netherlands for the past 22 years was admitted to the hospital with a 3-month history of recurrent fever and general weakness. The patient also reported night sweats, weight loss, and a dry cough. The symptoms developed after travel to Morocco, where he had experienced an episode of headache, shaking, vomiting, sweating, dizziness, and myalgia but no diarrhea. His past medical history was significant for symptomatic aortic valve stenosis, for which his aortic valve was replaced with a homograft in 2000; grade 2/4 mitral valve insufficiency; and chronic hepatitis C nonresponsive to treatment with (peg)interferon and ribavirin in 1998 and 2002 to 2003. His further medical history included chronic alcohol abuse, depression, and chronic tension headache. A routine transthoracic echocardiogram performed in the outpatient clinic a week before admission showed severe aortic homograft and mitral valve insufficiency.On physical examination on admission, the patient's temperature was 37.9°C and later that day it climbed to 40.0°C; his pulse was 100 beats per min, and his blood pressure was 116/58 mm Hg. Cardiac examination revealed a grade 3/6 systolic souffle and a grade 4/6 diastolic souffle, with no clear increase in intensity compared to that heard in earlier auscultations. There were no Janeway lesions, Osler's nodes, conjunctival hemorrhages, or signs of arterial emboli or septic pulmonary emboli. Laboratory tests showed a C-reactive protein level of 149 mg/liter, a leukocyte count of 7.2 ϫ 10 9 /liter with normal differentiation and a hemoglobin level of 7.1 mmol/liter. His chest X-ray was normal, and auramine staining of his stomach fluid and a test for antibodies to HIV were negative. On transesophageal echocardiography, new severe aortic homograft insufficiency was found, together with partial aortic valve destruction and dehiscence and mitral valve insufficiency. Artificial valve vegetation could not be ruled out. Blood cultures were taken, and empirical intravenous treatment with vancomycin, gentamicin, and rifampin for homograft endocarditis was started. Blood cultures taken on the day of admission became positive after 4 days. The Gram stain showed slightly curved Gram-negative rods which were oxidase, catalase, hippurate, and indoxyl acetate positive, corresponding to Campylobacter jejuni. The isolate was sensitive to clarithromycin, ciprofloxacin, and tetracycline by the disk diffusion method (Oxoid, Basingstoke, United Kingdom). The MIC of imipenem was 0.125 mg/liter, as determined by Etest (bioMérieux, Marcy l'Etoile, France) on Mueller-Hinton agar (Becton Dickinson, Heidelberg, Germany) with 5% sheep blood. Vancomycin, gentamicin, and ...
Campylobacter species cause a spectrum of illnesses in humans. The type of illness and the outcome is dependent on the virulence of the infecting pathogen strain and host immune status. Acute stress can seriously compromise host immunity and increase susceptibility to infection. Noradrenaline (NA) is a stress hormone. Several studies have shown that it stimulated growth and increased the pathogenicity of organisms including E. coli and Campylobacter jejuni. However, the effect of NA on other Campylobacter species is unknown. We have examined the effect of NA on growth rate, motility, invasion of T84 epithelial cells, and colonisation of chickens by diverse Campylobacter species. Campylobacter cultures grown with NA had reduced lag phases, increased growth rates, and higher final optical densities than controls. The motility of Campylobacter was also significantly increased in the presence of noradrenaline. Some of the Campylobacter strains tested also showed increased invasion of T84 epithelial cells, greater breakdown of tight junctions, and an enhanced potential to colonise chickens. Our results show that noradrenaline-induced enhancement of virulence of Campylobacter can influence the outcome of infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.